R N Channick
Overview
Explore the profile of R N Channick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
859
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hennigan S, Channick R, Silverman G
Lupus
. 2008 Jul;
17(8):754-6.
PMID: 18625655
Pulmonary hypertension is a common but underdiagnosed complication of systemic lupus erythematosus, which can be associated with significant morbidity and early mortality. Although often associated with anti-phospholipid antibodies, the etiology...
2.
Humbert M, Barst R, Robbins I, Channick R, Galie N, Boonstra A, et al.
Eur Respir J
. 2004 Sep;
24(3):353-9.
PMID: 15358690
The efficacy and safety of combining bosentan, an orally active dual endothelin receptor antagonist and epoprostenol, a continuously infused prostaglandin, in the treatment of pulmonary arterial hypertension (PAH) was investigated....
3.
Bresser P, Fedullo P, Auger W, Channick R, Robbins I, Kerr K, et al.
Eur Respir J
. 2004 Apr;
23(4):595-600.
PMID: 15083760
Pathophysiological findings in chronic thromboembolic pulmonary hypertension (CTEPH) have suggested that a secondary small vessel arteriopathy may contribute to the haemodynamic impairment observed in these patients. It was hypothesised that...
4.
Fesler P, Pagnamenta A, Vachiery J, Brimioulle S, Abdel Kafi S, Boonstra A, et al.
Eur Respir J
. 2003 Feb;
21(1):31-6.
PMID: 12570105
The purpose of this study was to determine the site of increased resistance using the arterial occlusion technique in patients with severe pulmonary hypertension. Pulmonary vascular resistance was partitioned in...
5.
Yung G, Kriett J, Jamieson S, Johnson F, Newhart J, Kinninger K, et al.
J Heart Lung Transplant
. 2001 Nov;
20(11):1224-7.
PMID: 11704484
Inhaled nitric oxide (INO) has been shown to improve oxygenation and decrease intrapulmonary shunt and pulmonary hypertension in various lung diseases. In this study we report a patient with end-stage...
6.
Channick R, Simonneau G, Sitbon O, Robbins I, Frost A, Tapson V, et al.
Lancet
. 2001 Oct;
358(9288):1119-23.
PMID: 11597664
Background: Endothelin 1, a powerful endogenous vasoconstrictor and mitogen, might be a cause of pulmonary hypertension. We describe the efficacy and safety of bosentan, a dual endothelin-receptor antagonist that can...
7.
Fedullo P, Auger W, Channick R, Kerr K, Rubin L
Clin Chest Med
. 2001 Oct;
22(3):561-81.
PMID: 11590849
Remarkable advances have occurred over the past 2 decades in the diagnostic approach, surgical management, and postoperative care of patients afflicted with chronic thromboembolic pulmonary hypertension. Despite these advances, a...
8.
Channick R, Rubin L
Clin Chest Med
. 2001 Oct;
22(3):539-45.
PMID: 11590847
Advances in the understanding of the molecular and cellular pathogeneses of PPH have led clinicians beyond simple pulmonary vasodilation as the only treatment for PPH and to a realization that...
9.
Robbins I, Barst R, Channick R, Rubin L
J Am Coll Cardiol
. 2001 Oct;
38(4):1267-8.
PMID: 11587028
No abstract available.
10.